Clin Mol Hepatol.
2016 Jun;22(2):238-240. 10.3350/cmh.2016.0103.
Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
- Affiliations
-
- 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical College, Ansan, Korea. gudwns21@medimail.co.kr
- KMID: 2373119
- DOI: http://doi.org/10.3350/cmh.2016.0103
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Bone Scintigraphy and Tenofovir-Induced Osteomalacia in Chronic Hepatitis B
- Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?
- Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?
- Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?
- Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles
